azacitidine has been researched along with Brain Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basavarajappa, BS; Nagre, NN; Shivakumar, M; Subbanna, S | 1 |
| Blum, W; Byrd, JC; Chan, KK; Devine, H; Devine, SM; Grever, MR; Hackanson, B; Heerema, NA; Huynh, L; Kefauver, C; Klisovic, RB; Liu, S; Liu, Z; Lozanski, G; Marcucci, G; Murgo, A; Plass, C; Vukosavljevic, T | 1 |
1 trial(s) available for azacitidine and Brain Disorders
| Article | Year |
|---|---|
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Brain Diseases; Decitabine; Fatigue; Humans; Infections; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Neutropenia; Remission Induction; Treatment Failure; Valproic Acid | 2007 |
1 other study(ies) available for azacitidine and Brain Disorders
| Article | Year |
|---|---|
A single day of 5-azacytidine exposure during development induces neurodegeneration in neonatal mice and neurobehavioral deficits in adult mice.
Topics: Animals; Animals, Newborn; Azacitidine; Brain; Brain Diseases; Disease Models, Animal; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Developmental; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurodegenerative Diseases; Phosphopyruvate Hydratase; Receptor, Cannabinoid, CB1; Signal Transduction; Social Behavior | 2016 |